BioCryst Pharmaceuticals BCRX Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$457.98M-757% | $263.86M+397% | -$8.78M+92.9% | -$35.71M+75.5% | -$53.47M+74.4% | ||
| $1.52M+19.5% | $1.39M+11.5% | $1.3M-4.1% | $1.28M-12.9% | $1.27M-18.3% | ||
| $79.73M+9.0% | $85.07M+30.0% | $82.61M+36.4% | $81.26M+46.2% | $73.13M+32.3% | ||
| $313.1M— | $347.37M— | $50.2M— | —— | —— | ||
| $2.73M+164% | $2.47M+120% | $2.34M+133% | $1.06M-45.3% | $1.03M-54.0% | ||
| —— | —— | —— | —— | —— | ||
| -$309.44M-680% | -$13.69M-125% | $87.59M+899% | $82.51M— | $53.38M— | ||
| —— | —— | —— | —— | —— | ||
| $62.09M— | -$349.93M— | -$135.99M— | —— | —— | ||
| $66.5M— | -$14.99M— | —— | —— | —— | ||
| $310.37M— | $344.9M— | $47.86M— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does BioCryst Pharmaceuticals generate?
- BioCryst Pharmaceuticals (BCRX) generated $313.1M in operating cash flow over the trailing twelve months.
- What is BioCryst Pharmaceuticals's free cash flow?
- After $2.7M of capital expenditures, BioCryst Pharmaceuticals's free cash flow was $310.4M over the trailing twelve months, up 448.8% year over year.
- Where does BioCryst Pharmaceuticals's cash flow data come from?
- Every line is extracted from BioCryst Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
